LOXL3 and melanoma: The same techniques in analyzing Loxl3 influence on melanoma progression and dissemination were used in a recent study by Vázquez-Naharro on animal models, and it showed that Loxl3 knockout and activation of Braf with concomitant inactivation of Pten reduced melanoma growth, while increasing latency and overall mice survival.